Price Alone Does Not Establish AI and Agentic ROI

AI accelerates disorder

One of the biggest challenges to responsible AI adoption is not the AI. It is organizational disorganization. AI increases activity across every function it touches: more models, vendors, use cases, agents, evidence, decisions, and stakeholders trying to determine what is valid, who has authority, and who is accountable. AI does not resolve fragmented organizations. It can catalyze and accelerate their fragmentation.

A vendor or entrepreneur that does not help wrangle that disorder does not create value, whatever its capability. It adds to the work someone else must organize, and that work is the hidden half of the iceberg. This argument is developed in Sherri Douville's LinkedIn post (September 23, 2026).

Two questions, not one

AI investment decisions increasingly require leaders to evaluate more than acquisition price and projected productivity. An organization needs to understand both the capital an initiative consumes and the institutional capacity required to make it successful.

TTIC built the AI Capital Decision Gate to help CFOs and finance leaders evaluate whether AI investments have sufficient evidence and accountability to justify continued capital. The AI Risk Stewardship Gate extends that logic to counterparties and relationships. It works from either side: health system to vendor, vendor to customer, investor to company, company to investor, or other consequential institutional relationships.

The gate is built for partnership with procurement, from both sides. Business owners who work through it with procurement before award or renewal give procurement the full picture of what a relationship will ask of the institution, early enough to shape scope, pricing, and contract terms. Entrepreneurs and vendors who work through it before they engage arrive with that picture already in hand.

The hidden half of the iceberg

Two counterparties can offer the identical expected value, revenue, savings, contract value, or AI productivity gain, and still be worth very different amounts once the relationship is priced in full.

A counterparty with a complete operating model consumes a modest, well-scoped amount of institutional capacity: implementation and integration, security and compliance, executive time, governance and risk management, ongoing support and coordination, and relationship management. A counterparty with a structurally incomplete operating model consumes far more of the same categories, plus customization and technical debt, escalation, remediation, and reputational risk. The same headline value can produce strong real net value in one relationship and weak net value in the other.

Real net value equals value created minus institutional capacity consumed. The price of a relationship is not simply what you pay. It is what your institution must absorb.

One cost line deserves a definition before anyone prices it: validation. Technical verification and validation of a system and clinical validation of its use are different work, carried by different functions, and priced differently. Before assigning costs, have the team consult TTIC's Verification, Validation & Evidence for AI resource so everyone agrees which kind of validation the relationship actually requires.

Real net value also has to survive the other side of the ledger. In September 2026, the Blue Cross Blue Shield Association published an analysis estimating that AI-enabled hospital coding added about $942 million in costs for its member plans across 2024 and 2025 compared with 2023, largely through secondary diagnoses that moved claims into higher-paying categories, reported by Healthcare Finance News. Hospitals and health systems respond that AI produces more complete records and more accurate payment. TTIC takes no position on that dispute. The lesson for any ROI case is narrower: a gain that depends on shifting cost to a party outside the relationship is not settled value. It may be contested, audited, or reversed, and the probability of that belongs in the downside, not in the contribution.

Invisible by default

AI disintermediates everything, and that makes everyone invisible by default. When buyers, partners, and investors meet a counterparty through an AI answer rather than a referral or a sales call, only what is carried by public, verifiable evidence gets found and represented accurately.

A counterparty that has not done that work borrows its visibility from you: your credibility, your introductions, your time spent explaining it. That is capacity your institution absorbs, and it belongs on the same side of the ledger as implementation, security, and coordination. The AI Risk Stewardship Gate now asks about it in both directions: whether a counterparty brings evidence-based distribution, and whether its visibility depends on borrowing yours.

The foundations that can't be skipped

Evidence-based distribution only works if there is evidence to distribute, and in healthcare that evidence has foundations many technology vendors try to skip. Clinical and technical leadership rests on a sustained, substantial body of high quality peer reviewed publications, rigorous technical work, clinically relevant evidence, and meaningful contributions to leading working groups that advance the field.

Trust grows when leaders make their methods and limitations open to scrutiny, credit contributors, disclose conflicts, protect clinical judgment, and take responsibility for outcomes. A counterparty that skips these foundations is asking its partners to lend it credibility it has not built, and the AI Risk Stewardship Gate prices that loan as capacity consumed.

The Economic Quantifiable Risk Model

The AI Risk Stewardship Gate includes the Economic Quantifiable Risk Model, also called the Risk-Pricing Worksheet, alongside five evidence domains and five possible determinations:

• Entrust: evidence supports positive net institutional contribution at the proposed level of commitment.
• Entrust With Conditions: proceed with explicit boundaries on the capacity committed, named ownership, and exposure limits.
• Limit Exposure: maintain the relationship only where the capacity it consumes and its downside are bounded and independently controllable.
• Deeper Diligence Required: material evidence gaps remain about contribution, burden, or technology exposure before capacity can be committed.
• Do Not Entrust Under Current Conditions: evidence does not show the relationship creates value after pricing the institutional capacity, risk, and accountability it would transfer.

These determinations are chosen by the leadership team, never computed. The worksheet informs the decision; it does not produce it.

This complements, rather than replaces, corporate finance

Actual capital allocation still depends on institution-specific strategy, cost of capital, portfolio constraints, financial forecasts, liquidity, and risk appetite. Those disciplines are already competently covered by most great health system and professional sports corporate finance departments. TTIC's contribution is the decision architecture that connects those financial disciplines to AI evidence, accountability, institutional capacity, counterparty risk, and downside exposure.

TTIC does not provide actuarial, insurance, investment, legal, clinical, credit-rating, or other professional services requiring separate licensure or certification. TTIC provides guidance and clarity but does not operate or execute for members or partner companies; the leadership team makes every determination, not TTIC.

Where to go next

References

• Douville, Sherri. LinkedIn post, September 23, 2026.
• “AI in hospital billing added nearly $1B in healthcare costs over 2 years.” Healthcare Finance News, September 2026.